Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHRA reclassifies several drugs

This article was originally published in The Tan Sheet

Executive Summary

The U.K. Medicines and Healthcare products Regulatory Agency eases restrictions on several medicines, including switching to nonprescription sale alclometasone dipropionate 0.05 percent for the short-term treatment of eczema and dermatitis in consumers 12 years and older. The agency also will allow the general sale (equivalent to OTC in the U.S.) of terbinafine hydrochloride 1 percent cutaneous solution for the treatment of tinea pedis in consumers 18 and older, and a combination pack of 2 mg nicotine gum and nicotine patches that release 15 mg over 16 hours for smoking cessation. Finally, the agency doubles the maximum pack size of the allergy relief medicine loratadine 10 mg available for general sale from seven tablets to 14 tablets
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103599

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel